Psychosis from subthalamic nucleus deep brain stimulator lesion effect

Surgical Neurology International

Volumn 4, Issue 1, 2013, Pages

  Widge, Alik S ^a   Agarwal, Pinky ^b   Giroux, Monique ^c   Farris, Sierra ^c   Kimmel, Ryan J ^a   Hebb, Adam O ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Evergreen Hospital   (United States)

^c Movement and Neuroperformance Center of Colorado   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Deep brain stimulation; neuromodulation; neurostimulation; Parkinson's disease; psychosis; subthalamic nucleus

Indexed keywords

AMANTADINE; BACLOFEN; CALCIUM CARBONATE; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; ENTACAPONE; ESCITALOPRAM; HALOPERIDOL; LORAZEPAM; OLANZAPINE; PRAMIPEXOLE; QUETIAPINE; SELEGILINE;

ADULT; AGITATION; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BRAIN DEPTH STIMULATION; CASE REPORT; DELUSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSTONIA; GRANDIOSE DELUSION; HUMAN; HYPERSEXUALITY; IMPULSIVENESS; INVOLUNTARY COMMITMENT; JEALOUSY; MALE; MENTAL DISEASE; MUSCLE RIGIDITY; PARANOIA; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; PSYCHOSIS; SIDE EFFECT; SUBTHALAMIC NUCLEUS; UNIFIED PARKINSON DISEASE RATING SCALE; VIOLENCE; VISUAL HALLUCINATION; VIVID DREAM;

EID: 84875169648     PISSN: None     EISSN: 21527806     Source Type: Journal    
DOI: 10.4103/2152-7806.106265     Document Type: Article

References (32)

1. Alberts JL, Hass CJ, Vitek JL, Okun MS. Are two leads always better than one: An emerging case for unilateral subthalamic deep brain stimulation in Parkinson's disease. Exp Neurol 2008;214:1-5.
2. Campbell MC, Black KJ, Weaver PM, Lugar HM, Videen TO, Tabbal SD, et al. Mood response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2012;24:28-36.
3. Cheramy A, Leviel V, Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature 1981;289:537-42.
4. Chopra A, Tye SJ, Lee KH, Matsumoto J, Klassen B, Adams AC, et al. Voltage-dependent mania after subthalamic nucleus deep brain stimulation in Parkinson's disease: A case report. Biol Psychiatry 2011;70:e5-7.
5. Chopra A, Tye SJ, Lee KH, Sampson S, Matsumoto J, Adams A, et al. Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: A review of the literature. J Neuropsychiatry Clin Neurosci 2012;24:102-10.
6. Diederich N, Alesch F, Goetz C. Visual hallucinations induced by deep brain stimulation in Parkinson's disease. Clin Neuropharmacol 2000;23:287-9.
7. Fernandez HH, Trieschmann ME, Friedman JH. Treatment of psychosis in Parkinsons disease: Safety considerations. Drug Saf 2003;26:643-59.
8. Greenhouse I, Gould S, Houser M, Hicks G, Gross J, Aron AR. Stimulation at dorsal and ventral electrode contacts targeted at the subthalamic nucleus has different effects on motor and emotion functions in Parkinson's disease. Neuropsychologia 2011;49:528-34.
9. Grill WM, Norman SE, Bellamkonda RV. Implanted neural interfaces: Biochallenges and engineered solutions. Annu Rev Biomed Eng 2009;11:1-24.
10. Hebb AO, Miller KJ. Semi-Automatic stereotactic coordinate identification algorithm for routine localization of Deep Brain Stimulation electrodes. J Neurosci Methods 2010;187:114-9.
11. Hebb AO, Poliakov AV. Imaging of deep brain stimulation leads using extended Hounsfield unit CT. Stereotact Funct Neurosurg 2009;87:155-60.
12. Herzog J, Reiff J, Krack P, Witt K, Schrader B, Müller D, et al. Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease. Mov Disord 2003;18:1382-4.
13. Keyser DL, Rodnitzky RL. NMS in PD after withdrawal or alteration in dopamine therapy. Arch Intern Med 1991;151:794-6.
14. Korf J, Zieleman M, Westerink BH. Dopamine release in substantia nigra? Nature 1967;260:257-8.
15. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-34.
16. Kulisevsky J, Berthier ML, Gironell A, Pascual-Sedano B, Molet J, Pares P. Mania following deep brain stimulation for Parkinson's disease. Neurology 2002;59:1421-4.
17. Montgomery EB Jr, Gale JT. Mechanisms of action of deep brain stimulation (DBS). Neurosci Biobehav Rev 2008;32:388-407.
18. Morel A. Stereotactic atlas of the human thalamus and basal ganglia. Informa Healthcare 2007.
19. Raucher-Chéné D, Charrel C-L, de Maindreville AD, Limosin F. Manic episode with psychotic symptoms in a patient with Parkinson's disease treated by subthalamic nucleus stimulation: Improvement on switching the target. J Neurol Sci 2008;273:116-7.
20. Romito LM, Raja M, Daniele A, Contarino MF, Bentivoglio AR, Barbier A, et al. Transient mania with hypersexuality after surgery for high-frequency stimulation of the subthalamic nucleus in Parkinson's disease. Mov Disord 2002;17:1371-4.
21. Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P, Albanese A. Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology 2002;58:1546-50.
22. Rothlind JC, Cockshott RW, Starr PA, Marks WJ Jr. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease. J Intl Neuropsychol Soc 2007;13:68-79.
23. Samii A, Kelly VE, Slimp JC, Shumway-Cook A, Goodkin R. Staged unilateral versus bilateral subthalamic nucleus stimulator implantation in Parkinson disease. Mov Disord 2007;22:1476-81.
24. Shotbolt P, Samuel M, Anthony D. Psychosis in Parkinson's disease: How should we treat it? Expert Rev Neurother 2006;6:1243-6.
25. Temel Y, Blokland A, Steinbusch HW, Visser-Vandewalle V. The functional role of the subthalamic nucleus in cognitive and limbic circuits. Prog Neurobiol 2005;76:393-413.
26. Temel Y, Kessels A, Tan S, Topdag A, Boon P, Visser-Vandewalle V. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: A systematic review. Parkinsonism Relat Disord 2006;12:265-72.
27. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-53.
28. Ulla M, Thobois S, Lemaire JJ, Schmitt A, Derost P, Broussolle E, et al. Manic behaviour induced by deep-brain stimulation in Parkinson's disease: Evidence of substantia nigra implication? J Neurol Neurosurg Psychiatry 2006;77:1363-6.
29. Vesper J, Haak S, Ostertag C, Nikkah G. Subthalamic nucleus deep brain stimulation in elderly patients: Analysis of outcome and complications. BMC Neurol 2007;7:7.
30. Winslow BD, Tresco PA. Quantitative analysis of the tissue response to chronically implanted microwire electrodes in rat cortex. Biomaterials 2010;31:1558-67.
31. Wolters EC, Berendse HW. Management of psychosis in Parkinson's disease. Curr Opin Neurol 2001;14:499-504.
32. Zonana J, Zimmerman M, McCarty SS, Ferrando S. A Case of abrupt-onset apathy, psychosis, and depression following deep brain stimulation in a patient with Parkinson's disease. Psychosomatics 2011;52:463-7.